Sarah Fogarty

Sarah Fogarty

Auto-generated profile, based on publicly available information

Sarah Fogarty

Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
ENEsther Nuebel
Esther Nuebel
JMJeffrey T Morgan
Jeffrey T Morgan
SFSarah Fogarty
Sarah Fogarty
JWJacob M Winter
Jacob M Winter
SLSandra Lettlova
Sandra Lettlova
JRJared Rutter
Jared Rutter

20 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LCLuis Cedeño-Rosario
Luis Cedeño-Rosario
QAQueren A. Alcantara
Queren A. Alcantara
NSNicole A. Sierra
Nicole A. Sierra
PPPraveena Prasad
Praveena Prasad
JWJillian Wright
Jillian Wright
JRJared Rutter
Jared Rutter
Metabolic state is tightly linked to cell fate, and expression of the mitochondrial pyruvate carrier (MPC), which imports pyruvate into mitochondria, is a robust marker of it. The transcriptional regulators that set metabolic state, however, remain poorly defined. In the liver, β-catenin is one of the determinants of metabolic zonation, and activating CTNNB1 mutations are frequent in hepatocellular carcinoma. Here we show that β-catenin regulates metabolic state in liver cancer cells. An unbiased CRISPR screen that uses endogenous MPC1 transcript abundance as the marker identifies CTNNB1 . Activating β-catenin pharmacologically or genetically reduces MPC1 and MPC2 transcript and protein levels, and MPC expression is also low in β-catenin-driven liver tumors in vivo. Beyond the MPC, β-catenin activation impairs assembly of respiratory Complexes III and IV, reduces mitochondrial DNA content and respiratory capacity, elongates mitochondrial networks and remodels the lipidome. Stable isotope tracing shows reduced entry of glucose- and lactate-derived carbon into the TCA cycle alongside increased oxidation of palmitate and oleate. These findings identify β-catenin as a regulator of metabolic state that drives a fuel switch from carbohydrate to fatty acid oxidation in liver cancer cells.